We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

180 hedge funds and large institutions have $1.35B invested in Pacira BioSciences in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

49% more call options, than puts

Call options by funds: $24.8M | Put options by funds: $16.6M

29% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 51

2% less capital invested

Capital invested by funds: $1.38B → $1.35B (-$28.8M)

3% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 37

2% less funds holding

Funds holding: 183 → 180 (-3)

Holders
180
Holders Change
-3
Holders Change %
-1.64%
% of All Funds
4.8%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
36
Increased
66
Reduced
51
Closed
37
Calls
$24.8M
Puts
$16.6M
Net Calls
+$8.21M
Net Calls Change
+$16.3M

Top Buyers

Rank Fund Capital Flow
1
Macquarie Group
Macquarie Group
Australia
+$39.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$30.2M
3
HM
HealthCor Management
New York
+$19.4M
4
GIM
Granahan Investment Management
Massachusetts
+$18.1M
5
Deutsche Bank
Deutsche Bank
Germany
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$49.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$41.3M
3
Millennium Management
Millennium Management
New York
-$24.3M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$21.6M
5
HCM
Hoplite Capital Management
New York
-$20.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
51
Charles Schwab
California
$4.4M +$236K +6,012 +5%
HCMT
52
Highland Capital Management (Texas)
Texas
$4.39M +$1.14M +29,179 +29%
Skandinaviska Enskilda Banken (SEB)
53
Skandinaviska Enskilda Banken (SEB)
Sweden
$4.25M +$4.87M +124,200 New
Morgan Stanley
54
Morgan Stanley
New York
$3.78M -$9.63M -245,919 -69%
BG
55
BlackRock Group
United Kingdom
$3.77M +$3.42M +87,372 +382%
RHJA
56
Rice Hall James & Associates
California
$3.51M +$1.13M +28,904 +39%
FAM
57
Fred Alger Management
New York
$3.45M -$3.85M -98,229 -49%
FCM
58
Frontier Capital Management
Massachusetts
$2.87M -$725K -18,496 -18%
Bank of America
59
Bank of America
North Carolina
$2.66M -$1.94M -49,628 -39%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$2.64M +$31.3K +800 +1%
USAA
61
United Services Automobile Association
Texas
$2.59M +$1.74M +44,400 +142%
CAM
62
Cortina Asset Management
Wisconsin
$2.56M +$2.93M +74,854 New
GC
63
Guggenheim Capital
Illinois
$2.35M -$83.9K -2,141 -3%
California Public Employees Retirement System
64
California Public Employees Retirement System
California
$2.26M -$180K -4,600 -7%
GLA
65
Great Lakes Advisors
Illinois
$2.23M +$2.56M +65,287 New
CS
66
Credit Suisse
Switzerland
$2.23M -$898K -22,925 -26%
Citigroup
67
Citigroup
New York
$2.17M +$2.19M +55,981 +740%
TD Asset Management
68
TD Asset Management
Ontario, Canada
$2.13M -$548K -14,000 -18%
AllianceBernstein
69
AllianceBernstein
Tennessee
$2.12M – – –
American Century Companies
70
American Century Companies
Missouri
$2.1M -$196K -5,006 -8%
Swiss National Bank
71
Swiss National Bank
Switzerland
$2.05M -$82.3K -2,100 -3%
TA
72
Teachers Advisors
New York
$2.03M +$29.5K +753 +1%
HCM
73
Highbridge Capital Management
New York
$1.91M +$2.19M +55,872 New
Allianz Asset Management
74
Allianz Asset Management
Germany
$1.82M +$2.08M +53,137 New
CCMH
75
Cornerstone Capital Management Holdings
New York
$1.79M +$2.05M +52,300 New
1 2
3
4 5

PCRX Hedge Fund Activity: Q3 2016 in Review

180 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2016, worth a combined $1.35B — down 2.1% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of PCRX and 36 opened new positions — a net loss of 1 holder — while 51 trimmed existing stakes and 66 added.

The largest buyer was Macquarie Group, adding an estimated $39.8M. The largest seller was Fidelity Investments, cutting an estimated $49.6M.

  • 180 institutional investors held Pacira BioSciences (PCRX) as of Q3 2016, down from 183 in Q2 2016.
  • Funds reported $1.35B of Pacira BioSciences stock for Q3 2016, down 2.1% quarter-over-quarter.
  • 36 funds opened new Pacira BioSciences positions in Q3 2016 and 37 closed out, a net change of -1 holder.
  • The largest Pacira BioSciences buyer in Q3 2016 was Macquarie Group, an estimated $39.8M added.
  • The largest Pacira BioSciences seller in Q3 2016 was Fidelity Investments, an estimated $49.6M sold.

Based on aggregated 13F filings for Q3 2016.